Acipimox


Acipimox
Systematic (IUPAC) name
5-methylpyrazine-2-carboxylic acid 4-oxide
Identifiers
CAS number	51037-30-0
ATC code	C10AD06
PubChem	5310993
Chemical data
Formula	C₆H₆N₂O₃
Mol. mass	154.124 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

Acipimox is a niacin derivative used as a hypolipidemic agent.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

v • d • e Lipid modifying agents (C10)

Statins	Atorvastatin • Cerivastatin^‡ • Fluvastatin • Lovastatin • Mevastatin • Pitavastatin • Pravastatin • Rosuvastatin • Simvastatin

Fibrates	Clofibrate^‡ • Bezafibrate • Aluminium clofibrate • Gemfibrozil • Fenofibrate • Simfibrate • Ronifibrate • Ciprofibrate • Etofibrate • Clofibride

Bile acid sequestrants	Colestyramine • Colestipol • Colextran • Colesevelam

Niacin and derivatives	Niceritrol • Niacin • Nicofuranose• Aluminium nicotinate• Nicotinyl alcohol • Acipimox

CETP inhibitors	Anacetrapib^† • Torcetrapib^§

Combinations	Niacin/lovastatin • Niacin/simvastatin • Ezetimibe/simvastatin

Other	Dextrothyroxine • Probucol • Tiadenol • Benfluorex • Meglutol • Omega-3-triglycerides • Magnesium pyridoxal 5-phosphate glutamate • Policosanol • Ezetimibe • Laropiprant^†, Lapaquistat^§

^†Undergoing clinical trials. ^‡Withdrawn from market. ^§Development terminated.